Blood Cancer Journal - Table of Contents alert Volume 3 May 2013

TABLE OF CONTENTS Volume 3, May 2013 In this issue Original Articles Letters to the Editor Sign up for e-alerts Web feed Advertisement Take part in our reader survey for a chance to win a MacBook Air As a reader of NPG's clinical and society-owned journals, we invite you to take part in a survey on your use of our journals and their associated websites. Take the survey and be entered into a prize draw for a MacBook Air* *Terms & conditions apply   Original Articles Top Stimulation of Toll-like receptor-1/2 combined with Velcade increases cytotoxicity to human multiple myeloma cells J Abdi, T Mutis, J Garssen and F Redegeld Blood Cancer J 2013 3: e119; 10.1038/bcj.2013.17 Abstract | Full Text The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics J How, J Sykes, M D Minden, V Gupta, K W L Yee, A D Schimmer, A C Schuh, S Kamel-Reid and J M Brandwein Blood Cancer J 2013 3: e116; 10.1038/bcj.2013.14 Abstract | Full Text Lipid raft-mediated Akt signaling as a therapeutic target in mantle cell lymphoma M Reis-Sobreiro, G Roué, A Moros, C Gajate, J de la Iglesia-Vicente, D Colomer and F Mollinedo Blood Cancer J 2013 3: e118; 10.1038/bcj.2013.15 Abstract | Full Text Letters to the Editor Top A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor Y Hattori, W Du, T Yamada, D Ichikawa, S Matsunami and M Matsushita Blood Cancer J 2013 3: e115; 10.1038/bcj.2013.13 Full Text MMSET is the key molecular target in t(4;14) myeloma F Mirabella, P Wu, C P Wardell, M F Kaiser, B A Walker, D C Johnson and G J Morgan Blood Cancer J 2013 3: e114; 10.1038/bcj.2013.9 Full Text Putative RNA-splicing gene LUC7L2 on 7q34 represents a candidate gene in pathogenesis of myeloid malignancies H Singh, A A Lane, M Correll, B Przychodzen, D B Sykes, R M Stone, K K Ballen, P C Amrein, J Maciejewski and E C Attar Blood Cancer J 2013 3: e117; 10.1038/bcj.2013.16 Full Text Advertisement Choose Scientific Reports for fast, efficient, open access publishing 93% of authors said they are likely or very likely to recommend Scientific Reports to their colleagues* 92% of authors would publish in Scientific Reports again* SUBMIT your paper today! *Nature Publishing Group author survey, data correct as of April 2013   You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.